Suspicious Order Monitoring (SOM): A Critical Compliance mandate for DEA registered Wholesale Drug Distributors

critical-compliance-dea

Suspicious Order Monitoring (SOM) is a vital compliance requirement under the Code of Federal Regulations (CFR) for DEA-registered wholesale drug distributors. At its core, SOM ensures that controlled substances are distributed responsibly by identifying unusual purchasing patterns that may signal diversion or misuse.
What Is Suspicious Order Monitoring?
Under DEA rules, distributors must establish a system to flag, investigate, and report certain transactions. This includes orders that are:

  • Unusually large compared to normal purchase history.
  • Uncharacteristic for the type of pharmacy or customer.
  • Placed with unusual frequency, suggesting possible diversion.

These safeguards are not optional. They form the backbone of a compliance program that protects both public safety and an organization’s reputation.
Orders of Interest vs. Suspicious Orders
One of the most important distinctions in SOM compliance is the difference between orders of interest and suspicious orders:

  • Orders of Interest (OOIs): Transactions that may require further review but do not automatically rise to the level of suspicion.
  • Suspicious Orders: Transactions that clearly meet DEA thresholds for reporting. These must be reported promptly to the DEA and not shipped until due diligence is complete.

Understanding this difference is critical for maintaining regulatory compliance and avoiding costly penalties.
Why SOM Matters More Than Ever
With ongoing opioid litigation and multi-billion-dollar settlements reshaping the pharmaceutical industry, DEA scrutiny has intensified. Distributors who fail to demonstrate robust SOM programs risk fines, license suspension, and long-term reputational harm.
An effective SOM program should integrate:

  • Automated data analytics to detect anomalies.
  • Documented policies and procedures.
  • Ongoing staff training on DEA requirements.

Final Thoughts
Suspicious Order Monitoring is more than a regulatory requirement—it is an essential safeguard against diversion and a cornerstone of responsible pharmaceutical distribution. In today’s compliance environment, distributors must treat SOM as a proactive strategy to protect their business, their partners, and the communities they serve.

Contact us for more information  solutions@pcgrx.com

Shape